Skip to main content
. 2018 Sep 10;13(9):e0203715. doi: 10.1371/journal.pone.0203715

Fig 3. Pv12 peptide in vitro binding to purified HLA-DRβ1* molecules.

Fig 3

A cut-off line is shown at 50% binding for selecting HBP for further evaluation of IC50 value. Each plot shows percentage epitope HLA-DRβ1* binding in this study and that for their control peptides.